Evaluation of positive and negative symptoms in schizophrenia
- 1 January 1986
- journal article
- research article
- Published by Cambridge University Press (CUP) in Psychiatry and Psychobiology
- Vol. 1 (2) , 108-122
- https://doi.org/10.1017/s0767399x00003199
Abstract
Summary Most investigators concur that schizophrenia is probably a heterogeneous group of disorders that share the common features of psychotic symptoms, partial response to neuroleptics, and a relatively poor outcome. The subdivision of schizophrenia into two subtypes, positive versus negative, has achieved wide acceptance throughout the world during recent years. This distinction has heuristic and theoretical appeal because it unites phenomenology, pathophysiology, and etiology into a single comprehensive hypothesis. In spite of its wide appeal, the distinction has a number of problems. These include the failure to distinguish between symptom syndromes and diseases; failure to deal with the mixed patient; failure to take longitudinal course into account; and failure to address conceptually and methodologically the distinction between positive and negative symptoms. This paper focuses primarily on the conceptual basis for two instruments designed to measure positive and negative symptoms, the Scale for the Assessment of Negative Symptoms (SANS) and the Scale for the Assessment of Positive Symptoms (SAPS), originally described in 1982. Since their description, these scales have been used in a variety of other centers. These scales are based on the hypothesis that negative symptoms represent a deficit or diminution in normal psychological functions wliile positive symptoms represent an excess or distortion of normal functions. Reliability data are now available from Italy, Spain, and Japan which suggest that these scales can be used reliably in cultural settings outside the United States. The results of these studies are summarized in this paper. In addition, a replication study involving a new sample of 117 schizophrenics collected at the University of Iowa is described. In this second study of the SANS and SAPS, internal consistency is found to be quite high in the SANS. Thus negative symptoms appear to be more internally correlated with one another than are positive symptoms. The implications of this result are discussed. A principal components analysis is used to explore the relationship between positive and negative symptoms. While the study reported in 1982 suggested that positive and negative symptoms are negatively correlated, in the present study they appear to be uncorrelated. Overall, the results suggest that the SANS and SAPS are useful comprehensive instruments for the evaluation of positive and negative symptoms. The relationship between these symptoms and external validators such as cognitive functioning or CT scan abnormalities will be reported in a subsequent investigation.Keywords
This publication has 30 references indexed in Scilit:
- Modular organization of prefrontal cortexTrends in Neurosciences, 1984
- Brain Peptides: What, Where, And Why?Science, 1983
- Positive and Negative Schizophrenia Symptoms and the Role of DopamineThe British Journal of Psychiatry, 1981
- Positive and Negative Schizophrenic Symptoms and the Role of DopamineThe British Journal of Psychiatry, 1980
- Molecular pathology of schizophrenia: more than one disease process?BMJ, 1980
- Antipsychotic drug doses and neuroleptic/dopamine receptorsNature, 1976
- CEREBRAL VENTRICULAR SIZE AND COGNITIVE IMPAIRMENT IN CHRONIC SCHIZOPHRENIAPublished by Elsevier ,1976
- Double-Blind Controlled Study of L-Dopa Therapy in SchizophreniaPsychiatry and Clinical Neurosciences, 1975
- Pathological Left-Handedness: An Explanaory ModelCortex, 1972
- The problem of the frontal lobe: A reinterpretationJournal of Psychiatric Research, 1971